Intercellular adhesion molecule 1 (ICAM-1) and insulinlike growth factor 1 (IGF-1) in patients with renal cell carcinoma.
Kleinknecht
S
S
Abteilung für Urologie, Universität Tübingen.
Bichler
K H
KH
Strohmaier
W L
WL
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002292:Carcinoma, Renal Cell / Q000097:blood* / Q000556:secondary / Q000628:therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007371:Interferon-gamma / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D010894:Piroxicam / Q000627:therapeutic use; D001613:beta 2-Microglobulin / Q000032:analysis
D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D007376:Interleukin-2; D009363:Neoplasm Proteins; D001613:beta 2-Microglobulin; D018799:Intercellular Adhesion Molecule-1; D010894:Piroxicam; D007334:Insulin-Like Growth Factor I; D007371:Interferon-gamma